Why the study?
Does the timing of appropriate antibiotic therapy confound the efficacy of recombinant human activated protein C in patients with severe sepsis?
Does the timing of appropriate antibiotic therapy confound the efficacy of recombinant human activated protein C in patients with severe sepsis?
Answers are grounded in this paper and cite their sources.
This letter highlights the critical importance of matching the timing of antibiotic administration between treatment and placebo groups in sepsis trials to avoid confounding mortality outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Grenade et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: